1219 views | 2 years ago
The Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care through the use of genomics. Their partner at Princess Margaret Cancer Centre,...
271 views | 2 years ago
El Perfil Genómico Integral (PGI) del ADN tumoral circulante (ctDNA) obtenido mediante biopsia líquida sanguínea proporciona resultados importantes para informar la selección de terapias posteriores....
1617 views | 2 years ago
Comprehensive Genomic Profiling (CGP) of circulating tumor DNA (ctDNA) from blood liquid biopsy provides important results to inform subsequent therapy selection. In this video interview, Dr. Atocha...
94686 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1134 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
372 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
216 views | 2 years ago
TruSight™ Oncology 500 ctDNA v2 is now available! Our next version comprehensive genomic profiling (CGP) from liquid biopsy (blood) offers higher analytical sensitivity from lower cfDNA input, faster...
1064 views | 2 years ago
This video shows the value of connecting your Illumina instrument to Illumina Proactive, a transformative program that brings enhanced service, support, and lab management capabilities to your lab....